Eculizumab

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3189 publications

Comparing Efficacy and Safety of Various Monoclonal Antibodies in Myasthenia Gravis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Comparing Efficacy and Safety of Various Monoclonal Antibodies in Myasthenia Gravis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Journal: Brain and behavior
Published: June 17, 2026

Eculizumab for rapidly progressive glomerulonephritis in children.

Eculizumab for rapidly progressive glomerulonephritis in children.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: June 16, 2026

Hockman A, Anuskiewicz S, Brennan E, et al. Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. Blood Adv. 2025;9(23):6096-6107.

Hockman A, Anuskiewicz S, Brennan E, et al. Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. Blood Adv. 2025;9(23):6096-6107.

Journal: Blood advances
Published: June 12, 2026

Complement C5 inhibitor crovalimab for the treatment of paroxysmal nocturnal hemoglobinuria.

Complement C5 inhibitor crovalimab for the treatment of paroxysmal nocturnal hemoglobinuria.

Journal: Expert review of clinical pharmacology
Published: May 29, 2026

Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?

Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: May 25, 2026

Infection risk mitigation with complement inhibitors in kidney disease.

Infection risk mitigation with complement inhibitors in kidney disease.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: May 23, 2026

Comment on "Consensus of the hematology society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)".

Comment on "Consensus of the hematology society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)".

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: May 21, 2026

Nipocalimab (Imaavy) for myasthenia gravis.

Nipocalimab (Imaavy) for myasthenia gravis.

Journal: The Medical letter on drugs and therapeutics
Published: May 15, 2026

Pregnancy-Associated Atypical Hemolytic Uremic Syndrome With Kidney Recovery Despite Delayed Initiation of Complement Blockade.

Pregnancy-Associated Atypical Hemolytic Uremic Syndrome With Kidney Recovery Despite Delayed Initiation of Complement Blockade.

Journal: Cureus
Published: April 30, 2026

Clinical analysis of eculizumab in the treatment of atypical hemolytic uremic syndrome in children

Clinical analysis of eculizumab in the treatment of atypical hemolytic uremic syndrome in children

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: April 15, 2026

Practical approach to pregnancy-associated thrombotic microangiopathies: navigating diagnostic challenges in resource-limited settings.

Practical approach to pregnancy-associated thrombotic microangiopathies: navigating diagnostic challenges in resource-limited settings.

Journal: BMJ case reports
Published: April 08, 2026

Family Planning in Neuroinflammatory Disease.

Family Planning in Neuroinflammatory Disease.

Journal: Continuum (Minneapolis, Minn.)
Published: April 02, 2026
Showing 1-12 of 3,189

Last Updated: 06/30/2026